Cole Pinnow

Cole Pinnow

Chief Commercial OfficeratCogent Biosciences· In proxies 2024–2025

Pay in FY2025+123% from the year before · Cogent Biosciences stock +355.4% the same year

Cole Pinnow was paid $8.8M in FY2025 (Dec), up 123%. Cogent Biosciences stock rose 355.4% that year.

Pay$100 in the stock at the end of FY23 → $604
Pay is from the Summary Compensation Table of each Cogent Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Cogent BiosciencesPublic company · 2 yr
    • Chief Commercial Officer2024 – Present · 2 yrStock in role +462%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?